Schonfeld Strategic Advisors’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$69.5K Buy
28,362
+16,930
+148% +$41.5K ﹤0.01% 1766
2025
Q1
$76.3K Buy
+11,432
New +$76.3K ﹤0.01% 1914
2023
Q4
Sell
-10,400
Closed -$213K 2009
2023
Q3
$213K Sell
10,400
-19,724
-65% -$404K ﹤0.01% 1269
2023
Q2
$599K Buy
+30,124
New +$599K 0.01% 1125
2023
Q1
Sell
-51,024
Closed -$999K 2433
2022
Q4
$999K Sell
51,024
-22,488
-31% -$440K 0.01% 1147
2022
Q3
$1.17M Buy
+73,512
New +$1.17M 0.01% 1154
2022
Q1
Sell
-41,400
Closed -$903K 2654
2021
Q4
$903K Sell
41,400
-29,870
-42% -$652K 0.01% 924
2021
Q3
$2.13M Buy
71,270
+35,067
+97% +$1.05M 0.02% 633
2021
Q2
$1.6M Sell
36,203
-298
-0.8% -$13.2K 0.02% 752
2021
Q1
$1.62M Sell
36,501
-3,111
-8% -$138K 0.02% 697
2020
Q4
$2.17M Buy
39,612
+13,591
+52% +$746K 0.03% 551
2020
Q3
$595K Sell
26,021
-24,934
-49% -$570K 0.01% 822
2020
Q2
$1.07M Buy
+50,955
New +$1.07M 0.03% 550
2020
Q1
Sell
-36,435
Closed -$829K 1442
2019
Q4
$829K Sell
36,435
-39,165
-52% -$891K 0.02% 562
2019
Q3
$881K Sell
75,600
-107,300
-59% -$1.25M 0.03% 503
2019
Q2
$2.74M Buy
182,900
+158,300
+643% +$2.37M 0.1% 240
2019
Q1
$432K Sell
24,600
-77,600
-76% -$1.36M 0.02% 734
2018
Q4
$1.51M Buy
102,200
+77,200
+309% +$1.14M 0.06% 378
2018
Q3
$616K Buy
+25,000
New +$616K 0.03% 535
2018
Q2
Sell
-24,460
Closed -$459K 918
2018
Q1
$459K Buy
+24,460
New +$459K 0.03% 494